International Journal of Medical Science and Pharmaceutical Research

Background: Squamous cell carcinomas are tumours originating from keratinocytes and they are among the most commonly encountered skin cancers worldwide. This tumour exhibits various degree of differentiation and subtypes, which is invariably important in prognostication and predictability of aggression and tumour recurrence.

The true prevalence of SCC in Nigeria is still debatable. However, The high frequency of cutaneous SCC significantly impacts the health system, making it a public health issue despite its low mortality rates and rare occurrence of metastases

Aims: The aim of this study was to examine  the proliferative index using ki-67 immuno peroxidase protein among the variants of squamous cell carcinoma diagnosed through routine biopsies at federal medical centre, umuahia, Abia state between 2012 and 2018

Methodology: Archival FFPE blocks were retrieved alongside relevant clinical data. Hematoxylin and eosin as well as immunohistochemistry using  monoclonal antibody against Ki-67 (BioCare CRM325C(RM)) for antigen expression on fresh 4-micron sections of tumour specimens was used. 

The H&E stained slides were interpreted under a light microscope and the immunohistochemical slides were viewed with Olympus CX22LED light microscope and brown nuclear staining was interpreted as positive staining for Ki-67 regardless of staining intensity. While bluish staining of the nucleus was interpreted as negative for Ki-67. The sections were examined at high power (x40) and 10 fields were chosen in the area showing most proliferation (areas showing most positive nuclear staining with Ki-67): 

Result:  In Overall, the Ki-67 index of all the cutaneous SCC in this study ranges from 2.3-80%, with a mean value of 24.7%.The Ki-67 index was variably expressed among the variants of SCC, of which the squamous cell carcinoma NOS have Ki-67 index range from 9.2-35.7% with a mean value of 20.2%, Adenosquamous  variant  have Ki-67 index range from 40-80% with a mean value of  55.3%, Acantholytic  variant, 23.5-45.2% and  a mean value of   32.0%, Verrucous squamous cell carcinoma, has Ki-67 index range of 2.3-10.5% with a mean value of  7.7%, that of Keratoacanthoma variant ranges from 2.4-10.7%  with a mean value of 7.0%

Conclusion: These findings may be helpful in prognostication as well as predictability of SCC tumour recurrence  and for the purpose of therapy and clinical follow up. Although a high proliferative index alone may not be the only factor responsible for the more aggressive behaviors exhibited by SCC, however, ki-67 nuclear stain is an important prognostic tool for predictability of the biologic behavior of SCC.

Squamous cell carcinoma, Ki-67, Proliferative index, Immunohistochemistry, Tumour variants, Prognostication

1. Ganiyu OO, Peter BO, Akinwumi OK, Olaejirinde OO, Hezekiah AM, Oreoluwa AS. Malignant skin lesions in Oshogbo. Pan African Medical Journal.2015; 20:253-260.
2. Lomas A, Leonardi-Bee J and Bath-Hextall F. A systemic review of world incidence of non-melanoma skin cancer. British journal of dermatology.2012;116:1069-108
3. Brougham ND, Tan ST. The incidence and risk factors of metástasis for cutaneous squamous cell carcinoma-implications on the T-classification system. J Surg Oncol. 2014; 110:876-82.
4. Leiter U, Keim U, Eigentler T, Katalinic A, Holleczek B, Martus P, et al. Incidence mortality, and trends of nonmelanoma skin cancer in Germany. J Invest Dermatol. 2017; 137:1860-7.
5. Lomas A, Leonardi-Bee J and Bath-Hextall F. A systemic review of world incidence of non-melanoma skin cancer. British journal of dermatology.2012;116:1069-1080
6. Gerald DF, Adesuwa NO. Malignant Skin Tumors in Benin City, South-South, Nigeria. Oman Medical Journal. 2013; 28(5):311-315
7. Bickers DR, Lim HW, Margolis D, Weinstock MA, Goodman C, Faulkner E, et al., The burden of skin diseases: 2004. A joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology,” Journal of the American Academy of Dermatology. 2006; 55(3):490–500.
8. Mohebet H, Gouda, Ghada AA, and Rasha ME. Value of P53, CD10 and Ki-67 in differentiation between Keratoacanthoma and squamous cell carcinoma. Med. J. Cairo university.2014; 82(1):795-801.
9. David EE, Daniela M, Richard AS, Rein W. World health Organisation classification of skin tumours.4th edition. Lyon. International Agency for Research on Cancer (IARC); 2018.
10. Crowson AN, Cynthia M, Martin C and Mihm JR. Biopsy interpretation of the skin. Philadelphia. Baltimore. Wolters Kluwer/Lippincott Williams and Wilkins; 2009
11. Rita GL, Ingeborg MB, Oddbjørn S and Lars AA. Ki-67expression is superior to mitotic count and novel proliferation markers PHH3, MCM4 and mitosin as a prognostic factor in thick cutaneous melanoma; Ladstein et al.Cancer 2010; 10:140-155.
12. Tilli CM, Ramaekers FC, Broers JL, Hutchison CJ and Neumann HA. Lamin expression in normal human skin, actinic keratosis, squamous cell carcinoma and basal cell carcinoma. British journal of dermatology. 2003; 148: 102–109
13. Al-Sader MH , Doyle E , Kay EW , Bennett M , Curran C , Milburn C and Leader M. Proliferation indexes-a comparison between cutaneous basal and squamous cell carcinoma j. clin. Path.1996;49:549-551.
14. Eyal K, Oscar H, Jacob F, Lior L, Letizia S and Hananya V. Ki-67 as a Biologic Marker of Basal Cell Carcinoma: A Retrospective Study. IMAJ.2014; 16:229-232
15. Alexandru M, Alex ES, Claudiu M, Alis MM, Roxana EZ, Cristiana ES and Mihaela N. P53, p16 and Ki-67 immunoexpression in cutaneous squamous cell carcinoma and its precursor lesions. Rom J Morpho Embryo. 2016; 57(2):691-696.
16. Pietro D, Giovanni P, Chiara P, Carlo C, Marco Z and Luca M. Another point of view on P16 and Ki-67 expression in melanotic and non-melanotic cutaneous lesions. Acta dermatovenerologica croatica.2013; 21(3):149-154
17. Amer T, Charif B, Safa Z, Khaled Z, Johnny N, Mahdi A and Mohammad YS.Ki-67 prognostic value in different histological grades of oral epithelia dysplasia and oral squamous cell carcinoma. AsianPac. J. cancer prev.2018; 19(11):3279-3286.
18. Vukelic J, Debrila-Dintinjana R, Dekanic A, Marijic B, Cubranic A and Braut T. The relevance of accessing the cell proliferation factor Ki-67 in squamous cell carcinoma of the larynx. Hindawi biomed research international.2019;1:1-7
19. Rodrigo GB, Guilherme MC, Alexandre CG, Carlos TC, Agricio NC, Albina MA and Eliane MI. Histologic correlation of expression of Ki-67 in squamous cell carcinoma of the glottis according to the degree of proliferation. Braz. J. otorhinolaryngol.2014; 80(4):290-295.
20. Ehrnaz A, Azadehzeinab T and Faezeh A. Comparative investigation on Ki-67 marker in oral squamous cell carcinoma and oral lichen planus by immunohistochemistry. Scholar’s journal of dental sciences.2017;4(10):434-439.